Simon Vann Jones

Psychedelics as a Treatment for Alzheimer’s Disease Dementia

Frontiers in Synaptic Neuroscience August 21, 2020 Simon Vann Jones, Allison O’kelly 60 citations

Currently, there are no disease-modifying treatments for Alzheimer's disease (AD) or any other dementia subtype. The renaissance in psychedelic research in recent years, in particular studies involving psilocybin and lysergic acid diethylamide (LSD), coupled with anecdotal reports of cognitive benefits from micro-dosing, suggests that they may have a therapeutic role in a range of psychiatric...